-Hisahiro Matsubara Researcher Activity Profile

Research Author Detailed Information 

Hisahiro Matsubara Publication Rate By Year

Hisahiro Matsubara has published 10 paper(s) in 2007, 2 paper(s) in 2008, for a total of 12 research publications in total.

Hisahiro H Matsubara Author Information

LAST NAME: matsubara

FIRST NAME: hisahiro

INITIALS: H

AFFILIATION:

Papers

Hisahiro Matsubara's Publication Record

1. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Year Published: 2007
Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. yakutsu@faculty.chiba-u.jp
2. Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells. Year Published: 2007
Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan.
3. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients. Year Published: 2007
Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
4. Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Year Published: 2007
Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba 260-8677, Japan. k-hayano@graduate.chiba-u.jp
5. [Two cases treated with trastuzumab as primary chemotherapy] Year Published: 2007
Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.
6. Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy. Year Published: 2007
7. [Two cases treated with trastuzumab as primary chemotherapy] Year Published: 2007
Dept. of Frontier Surgery, Graduate School of Medicine, Chiba University.
8. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. Year Published: 2007
Department of Frontier Surgery and the Research Center for Frontier Medical Engineering, Chiba University Graduate School of Medicine, Chiba, Japan.
9. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. Year Published: 2007
Department of Frontier Surgery and the Research Center for Frontier Medical Engineering, Chiba University Graduate School of Medicine, Chiba, Japan.
10. Long-term Results after Dissection of Positive Thoracic Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma. Year Published: 2008
Department of Frontier Surgery, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan, hshimada@faculty.chiba-u.jp.
11. Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy. Year Published: 2007
12. Improved Surgical Results in Thoracic Esophageal Squamous Cell Carcinoma: A 40-year Analysis of 792 Patients. Year Published: 2008
Department of Frontier Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuuou-ku, Chiba, 260-8670, Japan, hshimada@faculty.chiba-u.jp.